Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2021-09-24 20:09:14 UTC |
---|
Update Date | 2021-09-24 20:09:15 UTC |
---|
HMDB ID | HMDB0304858 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Selumetinib |
---|
Description | Selumetinib, also known as arry 142886 or azd 6244, belongs to the class of organic compounds known as benzimidazoles. These are organic compounds containing a benzene ring fused to an imidazole ring (five member ring containing a nitrogen atom, 4 carbon atoms, and two double bonds). Based on a literature review a significant number of articles have been published on Selumetinib. |
---|
Structure | CN1C=NC2=C1C=C(C(O)=NOCCO)C(NC1=C(Cl)C=C(Br)C=C1)=C2F InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26) |
---|
Synonyms | Value | Source |
---|
ARRY 142886 | ChEBI | ARRY-142886 | ChEBI | ARRY142886 | ChEBI | AZD 6244 | ChEBI | AZD-6244 | ChEBI | AZD6244 | ChEBI | Selumetinibum | ChEBI | Selumetinib | MeSH |
|
---|
Chemical Formula | C17H15BrClFN4O3 |
---|
Average Molecular Weight | 457.68 |
---|
Monoisotopic Molecular Weight | 456.000009 |
---|
IUPAC Name | 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboximidic acid |
---|
Traditional Name | 6-[(4-bromo-2-chlorophenyl)amino]-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-1,3-benzodiazole-5-carboximidic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN1C=NC2=C1C=C(C(O)=NOCCO)C(NC1=C(Cl)C=C(Br)C=C1)=C2F |
---|
InChI Identifier | InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26) |
---|
InChI Key | CYOHGALHFOKKQC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzimidazoles. These are organic compounds containing a benzene ring fused to an imidazole ring (five member ring containing a nitrogen atom, 4 carbon atoms, and two double bonds). |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzimidazoles |
---|
Sub Class | Not Available |
---|
Direct Parent | Benzimidazoles |
---|
Alternative Parents | |
---|
Substituents | - Benzimidazole
- Aniline or substituted anilines
- Bromobenzene
- Chlorobenzene
- Halobenzene
- Aryl bromide
- Aryl chloride
- Aryl fluoride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- N-substituted imidazole
- Azole
- Heteroaromatic compound
- Vinylogous amide
- Imidazole
- Amino acid or derivatives
- Azacycle
- Carboxylic acid derivative
- Secondary amine
- Organooxygen compound
- Primary alcohol
- Organohalogen compound
- Organobromide
- Amine
- Hydrocarbon derivative
- Alcohol
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Organochloride
- Organofluoride
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Not Available |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Selumetinib,3TMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3Cl)[Si](C)(C)C)=C(C(=NOCCO[Si](C)(C)C)O[Si](C)(C)C)C=C21 | 3297.9 | Semi standard non polar | 33892256 | Selumetinib,3TMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3Cl)[Si](C)(C)C)=C(C(=NOCCO[Si](C)(C)C)O[Si](C)(C)C)C=C21 | 2835.2 | Standard non polar | 33892256 | Selumetinib,3TMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3Cl)[Si](C)(C)C)=C(C(=NOCCO[Si](C)(C)C)O[Si](C)(C)C)C=C21 | 3898.5 | Standard polar | 33892256 | Selumetinib,3TBDMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3Cl)[Si](C)(C)C(C)(C)C)=C(C(=NOCCO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C=C21 | 3892.7 | Semi standard non polar | 33892256 | Selumetinib,3TBDMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3Cl)[Si](C)(C)C(C)(C)C)=C(C(=NOCCO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C=C21 | 3290.2 | Standard non polar | 33892256 | Selumetinib,3TBDMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3Cl)[Si](C)(C)C(C)(C)C)=C(C(=NOCCO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C=C21 | 4033.2 | Standard polar | 33892256 |
|
---|
| MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Selumetinib 10V, Positive-QTOF | splash10-0a6r-5003900000-ad7092eb9e18e8c63f94 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Selumetinib 20V, Positive-QTOF | splash10-004i-2009100000-3858abbf1afdf7e8f6f3 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Selumetinib 40V, Positive-QTOF | splash10-002b-9006000000-a56224b65db84bc5eb20 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Selumetinib 10V, Negative-QTOF | splash10-0udi-1002900000-035bcb0c187f51cde944 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Selumetinib 20V, Negative-QTOF | splash10-0udl-4009400000-abdf560a6933bf91112d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Selumetinib 40V, Negative-QTOF | splash10-0ug0-4229000000-d09a5ee27c45ba878051 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Selumetinib 10V, Positive-QTOF | splash10-0a4i-0000900000-73d7e6711f3af0f387fc | 2021-10-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Selumetinib 20V, Positive-QTOF | splash10-053r-0009800000-9075ace0cdf9bf6369a0 | 2021-10-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Selumetinib 40V, Positive-QTOF | splash10-0udi-0139100000-acd888a1944907e50ac2 | 2021-10-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Selumetinib 10V, Negative-QTOF | splash10-0udi-0001900000-37aa71a8f8f030f74806 | 2021-10-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Selumetinib 20V, Negative-QTOF | splash10-0f6x-4009500000-567c825d54ceb9e7e6a4 | 2021-10-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Selumetinib 40V, Negative-QTOF | splash10-0udi-3009000000-6f51161796301c9b94b6 | 2021-10-22 | Wishart Lab | View Spectrum |
|
---|